ROR2 played as tumor promoter in renal cancer [11], chronic lymphocytic leukemia [12], malignant melanoma [13], whereas its high expression was shown to be related with better prognosis in patients with colorectal cancer [14, 15], liver cancer [16], medulloblastoma [17] and endometrial cancer [18]. Here, ROR2 is linked to neoplasm.